印度在状细胞疾病中使用氧尿素的经验:一篇25年的系统审查
Dipty Jain1, Devang Sarvaiya2, Sucheta Mehta2
1Department of Pediatrics, Datta Meghe Institute of Medical Sciences, Wardha, Maharashtra, India.
The Indian journal of medical research
|September 24, 2025
概括
氧尿素 (HU) 通过增加胎儿血红蛋白和减少并发症,在印度有效治疗状细胞疾病 (SCD). 这一审查证实了HUHU的证实.
科学领域:
- 血液学 血液学 血液学
- 遗传学 是一个遗传学.
- 公共卫生 公共卫生
背景情况:
- 状细胞疾病 (SCD) 是一种遗传性疾病,导致红细胞变形和严重的健康问题.
- 在印度,SCD是一个主要的健康挑战,特别是在部落社区.
- 水氧尿素 (HU) 是SCD的关键疗法,已知可以提高胎儿血红蛋白 (HbF) 和减轻并发症.
研究的目的:
- 系统地审查Hydroxyurea (HU) 在患有状细胞疾病 (SCD) 的印度患者的疗效和安全性.
- 评估HU对HbF水平,血管封闭性危机 (VOC) 和其他与SCD相关的发病率的影响.
主要方法:
- 对2000年1月至2024年8月间发表的27项印度研究进行了系统审查.
- 包括临床试验,前性/后性研究和观察性队列,涉及3817名SCD患者.
- 分析了关于HbF水平,VOC频率,输血需求,住院和不良事件的数据.
主要成果:
- 在印度SCD患者中,氧尿素显著增加HbF水平 (10.9-77.3%).
- 华为显示了VOC频率 (79-93%) 和输血需求 (50-85%) 的大幅降低.
- 医院住院和贫血病的情况有所改善;一般来说,HU是安全的,副作用是轻微的,可逆的.
结论:
- 氧尿素是一种有效的疾病修饰疗法,用于患有状细胞疾病的印度患者.
- HU耐受性很好,提供显著的临床益处和改善患者的治疗结果.
- 这些发现支持在印度人口中使用HU来管理SCD.
相关概念视频
Hemodialysis II: Procedure and Complications
547
DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
547
Acute Kidney Injury IV: Diagnostic Studies and Prevention
238
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
238
Hemodialysis III: Nursing Management
675
The nursing management of a patient undergoing hemodialysis includes several critical steps, starting with a thorough assessment before the procedure.Before the Hemodialysis ProcedureFirst, record the patient's vital signs—blood pressure, heart rate, respiratory rate, and temperature—to establish a baseline. This baseline is essential for detecting conditions such as hypotension that could impact the patient's response to dialysis. Document the patient's pre-dialysis weight, as this...
675
Continuous Renal Replacement Therapy
713
Continuous Renal Replacement Therapy, also known as CRRT, is a procedural treatment for acute kidney injury (AKI) that gradually removes uremic toxins and fluids while maintaining acid-base balance and stabilizing electrolytes. It is particularly useful for hemodynamically unstable patients. Unlike intermittent hemodialysis, which is faster, CRRT provides a gentler approach over 24 hours, closely mimicking the function of natural kidneys. However, CRRT is not ideal for patients with...
713
Hemodialysis I: Introduction
1.1K
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
1.1K
iPS Cell Differentiation
3.0K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.0K


